NEM
30
2
HST
53
4
EA
41
3
CI
35
2
MHK
25
5
FTI
61
5
JNPR
59
3
LH
33
3
GRMN
53
3
GD
42
4
HP
44
14
AMP
43
2
ESS
44
5
KHC
11
2
FSLR
50
6
KEY
24
2
BF.B
35
2
OXY
42
17
AON
25
4
KIM
58
2
NEM
30
2
HST
53
4
EA
41
3
CI
35
2
MHK
25
5
FTI
61
5
JNPR
59
3
LH
33
3
GRMN
53
3
GD
42
4
HP
44
14
AMP
43
2
ESS
44
5
KHC
11
2
FSLR
50
6
KEY
24
2
BF.B
35
2
OXY
42
17
AON
25
4
KIM
58
2
Financhill
Back

Sophia Genetics SA 10K Form

Sell
47

SOPH
Sophia Genetics SA

Last Price:
$3.25
Seasonality Move:
40.96%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SOPH News And Ratings

See the #1 stock for the next 7 days that we like better than SOPH

SOPH Financial Statistics

Sales & Book Value

Annual Sales: $62.4M
Cash Flow: $-10.7M
Price / Cash Flow: 0
Annual Sales: $1.71
Price / Book: 1.85

Profitability

EPS (TTM): -1.09000
Net Income (TTM): $-71.4M
Gross Margin: $42.9M
Return on Equity: -52.73%
Return on Assets: -37.54%

Sophia Genetics SA Earnings Forecast

Key Sophia Genetics SA Financial Ratios

  • The Gross Profit Margin over the past 5 years for SOPH is 68.80%.
  • The Selling, General & Administrative Expenses for SOPH have been equal to 131.03% of Gross Profit Margin.
  • The Research & Development expenses have been 59.27% of Revenue.
  • The Interest Expense is -0.74% of Operating Income.
  • The Net Earning history of SOPH is -126.63% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 1 years.

Sophia Genetics SA Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Technology
Sector: Health Care
Current Symbol: SOPH
Website: sophiagenetics.com

Debt

Debt-to-Equity Ratio: 0.12
Current Ratio: 3.8
Quick Ratio: 3.42

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SOPH Technical Analysis vs Fundamental Analysis

Sell
47
Sophia Genetics SA (SOPH) is a Sell

Is Sophia Genetics SA a Buy or a Sell?